Regorafenib combined with transarterial chemoembolization for unresectable hepatocellular carcinoma: a real-world study. Han Y, Cao G, Sun B, Wang J, et al. BMC Gastroenterol 2021;21:393.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Han Y, Cao G, Sun B, Wang J, et al. Regorafenib combined with transarterial chemoembolization for unresectable hepatocellular carcinoma: a real-world study. BMC Gastroenterol 2021;21:393.
PMID: 34670512